News | June 03, 2021
Sun Pharma and Ferring Pharmaceuticals to introducing CARITEC in India
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
Sun Pharma is granted rights for co-marketing of the drug in India in the private market under the brand name CARITEC
The company reported net profit for FY21 at Rs. 2,903.8 crore, lower by 23% over last year
Baricitinib is used in combination with remdesivir for the treatment of suspected or laboratory confirmed COVID-19
The consideration to be paid will be AUD 2.0 mn for 12.5% stake.
Subscribe To Our Newsletter & Stay Updated
